SALARIUS PHARMACEUTICALS INC's ticker is SLRX and the CUSIP is 79400X107. A total of 16 filers reported holding SALARIUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | -60.0% | 11,472 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | -58.3% | 11,472 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $12,000 | 0.0% | 11,472 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $12,000 | -29.4% | 11,472 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $17,000 | +70.0% | 11,472 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $10,000 | 0.0% | 11,472 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $10,000 | -33.3% | 11,472 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $15,000 | +87.5% | 11,472 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $8,000 | -81.4% | 11,472 | 0.0% | 0.00% | -80.0% |
| Q4 2019 | $43,000 | -63.9% | 11,472 | -47.3% | 0.01% | -64.3% |
| Q3 2019 | $119,000 | – | 21,772 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 258,249 | $341,000 | 0.17% |
| Laird Norton Wetherby Wealth Management, LLC | 39,746 | $52,000 | 0.01% |
| RMR Wealth Builders | 3,000 | $4,000 | 0.00% |
| Douglass Winthrop Advisors, LLC | 78,806 | $104,000 | 0.00% |
| Financial Advocates Investment Management | 11,472 | $15,000 | 0.00% |
| NORTHERN TRUST CORP | 12,788 | $17,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 18,330 | $24,000 | 0.00% |
| DEUTSCHE BANK AG\ | 1,630 | $2,000 | 0.00% |
| MORGAN STANLEY | 10,400 | $14,000 | 0.00% |